Fresenius Medical Care is set to buy NxStage Medical for about $2 billion. The takeover will bolster Fresenius’ presence in the at-home dialysis market, positioning it to continue profiting if ...
NxStage Medical ($NXTM) is primarily focused on the at-home dialysis market, but its newest product is devoted to making dialysis treatment in centers easier and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results